Journal rankings · indicator year 2022
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2022
Hematology journal rankings 2022
83 ranked journals · Subfield in Medicine
Hematology has 83 ranked journals in 2022. The median journal has an OJR of 0.68, below the world average of 1.00, unchanged on 2021; Q1 starts at OJR 1.06. The top three are The Lancet Haematology, Blood, and Blood Cancer Journal.
Ranks and citation indicators: 2022. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2019–2021, the window the 2022 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery1,001
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health310
- Cardiology and Cardiovascular Medicine296
- Oncology245
- Infectious Diseases243
- Epidemiology196
- Neurology176
- Radiology, Nuclear Medicine and Imaging165
- Physiology162
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health147
- Hematology83
Show all 42 subfields
- Orthopedics and Sports Medicine123
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology97
- Obstetrics and Gynecology88
- Rheumatology65
- Nephrology62
- Reproductive Medicine54
- Complementary and alternative medicine51
- Pharmacology51
- Emergency Medicine43
- Geriatrics and Gerontology38
- Rehabilitation36
- Otorhinolaryngology34
- Pathology and Forensic Medicine29
- Hepatology28
- Immunology and Allergy24
- Critical Care and Intensive Care Medicine23
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
83 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2021. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2019–2021, the window the 2022 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2019–2021 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2013 to 2022. | Compare |
|---|---|---|---|---|---|---|---|
1The Lancet HaematologyElsevier BV · Netherlands | 3.75Q1 | 13.03 2.94 down from 2021 | 382 | 31% | $7,280 | ||
2BloodElsevier BV · United States | 2.97Q1 | 10.19 1.97 down from 2021 | 2,357 | 13% | $5,500 | ||
3Blood Cancer JournalOASpringer Nature · United Kingdom | 2.77Q1 | 9.60 1.82 up from 2021 | 415 | 100% | $5,290 | ||
4Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 2.67Q1 | 10.98 5.01 down from 2021 | 1,067 | 97% | $3,750 | ||
5Blood ReviewsElsevier BV · United Kingdom | 2.58Q1 | 7.60 1.95 down from 2021 | 204 | 49% | $5,220 | ||
6LeukemiaSpringer Nature · United Kingdom | 2.53Q1 | 8.91 1.15 down from 2021 | 1,054 | 75% | $5,190 | ||
7Blood Cancer DiscoveryAmerican Association for Cancer Research · United States | 2.41Q1 | 8.44 2.11 up from 2021 | 98 | 58% | — | ||
8Blood AdvancesOAElsevier BV · United States | 2.29Q1 | 7.83 0.56 down from 2021 | 1,812 | 100% | $3,800 | ||
9American Journal of HematologyWiley · United States | 2.14Q1 | 7.05 0.73 down from 2021 | 942 | 59% | $5,450 | ||
10HaematologicaOAFerrata Storti Foundation · Italy | 1.61Q1 | 5.37 0.36 down from 2021 | 1,401 | 100% | $2,157 | ||
11AnemiaOAHindawi Publishing Corporation · United Kingdom | 1.42Q1 | 3.82 1.27 up from 2021 | 45 | 100% | $1,100 | ||
12Therapeutic Advances in HematologyOASAGE Publishing · United Kingdom | 1.40Q1 | 3.77 2.21 down from 2021 | 150 | 100% | $2,650 | ||
13Transfusion Medicine ReviewsElsevier BV · United States | 1.33Q1 | 5.54 3.18 down from 2021 | 99 | 28% | $3,970 | ||
14Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.29Q1 | 3.52 1.43 down from 2021 | 163 | 31% | $3,790 | ||
15Research and Practice in Thrombosis and HaemostasisOAElsevier BV · United States | 1.24Q1 | 4.08 1.15 down from 2021 | 400 | 100% | $2,250 | ||
16HematologyAmerican Society of Hematology · United States | 1.24Q1 | 3.98 0.39 up from 2021 | 270 | 99% | — | ||
17Seminars in HematologyElsevier BV · United States | 1.21Q1 | 4.15 1.02 up from 2021 | 71 | 51% | $4,070 | ||
18Pediatric RheumatologyOABioMed Central · United Kingdom | 1.17Q1 | 3.00 1.09 down from 2021 | 338 | 100% | $3,090 | ||
19British Journal of HaematologyWiley · United Kingdom | 1.13Q1 | 4.13 0.81 down from 2021 | 1,979 | 53% | $5,190 | ||
20Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 1.10Q1 | 5.02 1.18 down from 2021 | 338 | 38% | — | ||
21Bone Marrow TransplantationSpringer Nature · United Kingdom | 1.06Q1 | 3.31 0.62 down from 2021 | 995 | 49% | $4,990 | ||
22Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.04Q2 | 3.51 0.63 down from 2021 | 1,060 | 100% | $3,650 | ||
23Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 1.03Q2 | 2.44 1.55 down from 2021 | 165 | 100% | $1,670 | ||
24Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 1.02Q2 | 2.58 1.71 down from 2021 | 145 | 46% | $3,730 | ||
25Current Opinion in HematologyLippincott Williams & Wilkins · United States | 1.01Q2 | 3.62 0.35 up from 2021 | 181 | 47% | — | ||
26Expert Review of HematologyTaylor & Francis · United Kingdom | 0.99Q2 | 3.29 0.05 up from 2021 | 307 | 27% | — | ||
27PlateletsOAInforma · United Kingdom | 0.97Q2 | 3.63 0.03 up from 2021 | 415 | 59% | $2,970 | ||
28European Journal Of HaematologyWiley · United Kingdom | 0.95Q2 | 3.36 0.30 down from 2021 | 487 | 51% | $4,650 | ||
29Current Research in Translational MedicineElsevier BV · France | 0.93Q2 | 3.71 0.56 down from 2021 | 94 | 31% | $3,700 | ||
30Journal of Blood MedicineOADove Medical Press · New Zealand | 0.92Q2 | 2.67 0.07 down from 2021 | 212 | 100% | $2,320 | ||
31HämostaseologieThieme Medical Publishers (Germany) · Germany | 0.90Q2 | 3.31 0.90 up from 2021 | 177 | 78% | — | ||
32HemaSphereOAWolters Kluwer · United States | 0.85Q2 | 3.24 0.51 up from 2021 | 403 | 100% | $2,480 | ||
33Annals of Laboratory MedicineOASeoul National University · South Korea | 0.84Q2 | 3.49 0.04 up from 2021 | 298 | 100% | — | ||
34Annals of HematologyOASpringer Science+Business Media · Germany | 0.84Q2 | 2.96 0.27 down from 2021 | 1,106 | 32% | $4,590 | ||
35HaemophiliaWiley · United Kingdom | 0.81Q2 | 3.31 0.08 up from 2021 | 730 | 48% | $4,760 | ||
36Vox SanguinisWiley · United Kingdom | 0.77Q2 | 2.75 0.54 down from 2021 | 419 | 31% | $4,150 | ||
37Journal of Clinical ApheresisWiley · United States | 0.74Q2 | 1.56 1.82 down from 2021 | 242 | 37% | $3,920 | ||
38Acta HaematologicaKarger Publishers · Switzerland | 0.74Q2 | 2.63 0.22 down from 2021 | 307 | 36% | — | ||
39Experimental HematologyElsevier BV · United States | 0.73Q2 | 2.60 0.40 down from 2021 | 262 | 100% | $3,250 | ||
40Mediterranean Journal of Hematology and Infectious DiseasesOAPAGEPress (Italy) · Italy | 0.71Q2 | 2.64 0.39 down from 2021 | 214 | 100% | $647 | ||
41TransfusionWiley · United States | 0.69Q2 | 2.79 0.15 down from 2021 | 1,423 | 31% | $4,100 | ||
42International Journal of Laboratory HematologyWiley · United Kingdom | 0.68Q2 | 2.37 0.38 down from 2021 | 769 | 22% | $3,880 | ||
43International Journal of HematologySpringer Science+Business Media · Japan | 0.68Q3 | 2.31 0.22 down from 2021 | 619 | 32% | $4,390 | ||
44HematologyOAManey Publishing · United Kingdom | 0.65Q3 | 2.33 0.01 down from 2021 | 279 | 100% | $2,557 | ||
45Leukemia ResearchElsevier BV · United Kingdom | 0.63Q3 | 2.02 0.55 down from 2021 | 418 | 19% | $3,910 | ||
46Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.62Q3 | 1.84 0.34 down from 2021 | 856 | 8% | $3,890 | ||
47Cytometry Part B Clinical CytometryWiley · United States | 0.61Q3 | 2.48 0.61 down from 2021 | 201 | 25% | $3,800 | ||
48Clinical Hematology InternationalOASpringer Nature · Netherlands | 0.61Q3 | 1.86 0.46 up from 2021 | 73 | 100% | — | ||
49Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.58Q3 | 1.81 0.16 down from 2021 | 1,424 | 28% | — | ||
50Pediatric Hematology and OncologyTaylor & Francis · United Kingdom | 0.52Q3 | 1.40 0.27 down from 2021 | 248 | 23% | — |
Subfields of Medicine, with Hematology highlighted.
- Surgery1,001
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health310
- Cardiology and Cardiovascular Medicine296
- Oncology245
- Infectious Diseases243
- Epidemiology196
- Neurology176
- Radiology, Nuclear Medicine and Imaging165
- Physiology162
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health147
- Orthopedics and Sports Medicine123
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology97
- Obstetrics and Gynecology88
- Hematology83
- Rheumatology65
- Nephrology62
- Reproductive Medicine54
- Complementary and alternative medicine51
- Pharmacology51
- Emergency Medicine43
- Geriatrics and Gerontology38
- Rehabilitation36
- Otorhinolaryngology34
- Pathology and Forensic Medicine29
- Hepatology28
- Immunology and Allergy24
- Critical Care and Intensive Care Medicine23
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2022. Corpus-wide, 89.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
17 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2019–2021, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2022. Publication window: 2019–2021. How these summaries are calculated
- Ranked journals
- 83
- Window papers (baseline)
- 45,948 +17.8% from indicator year 2019
- Median OJR
- 0.68287 -0.01% from indicator year 2019
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2019–2021 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.